Related Experiment Videos
Current topics in neuropathology. Cushing's disease
Neuropathology and Applied Neurobiology
|November 1, 1985
Summary
Cushing's disease is often caused by pituitary corticotroph microadenomas producing ACTH and other peptides. Selective adenomectomy is a common treatment, though some cases stem from central abnormalities requiring further study.
Area of Science:
- Endocrinology
- Neurosurgery
- Pathology
Background:
- Cushing's disease is frequently caused by pituitary corticotroph microadenomas, accounting for up to 90% of cases.
- These tumors can co-secrete ACTH and other pro-opiomelanocortin-derived peptides, potentially explaining diverse clinical manifestations.
- A minority of cases may originate from primary hypothalamic or central abnormalities, presenting as normal pituitary glands or hyperplasia.
Purpose of the Study:
- To elucidate the underlying pathology of Cushing's disease using advanced investigative techniques.
- To correlate hormonal secretion and pathological findings for better disease subtyping.
- To improve diagnostic capabilities for identifying distinct patient groups.
Main Methods:
- Application of electron microscopy and immunohistochemistry to pituitary tissue.
- Analysis of hormone secretion and responses to biochemical testing.
- Correlation of clinical presentation with pathological findings.
Main Results:
- Confirmation that corticotroph microadenomas are the predominant cause of Cushing's disease.
- Identification of co-secretion of various peptides by pituitary tumors.
- Recognition of a subset of patients with central abnormalities, not identifiable by current biochemical tests.
Conclusions:
- Selective transsphenoidal adenomectomy is a primary treatment due to the high incidence of single microadenomas.
- The current inability to biochemically distinguish central abnormalities necessitates further research.
- Prospective studies correlating hormone data and pathology are crucial for understanding Cushing's disease variants.